Nuclear Medicine
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
Showing 41 - 60 of 419 results
ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
Scientists at ANSTO characterise structures with atomic detail using probes such as x-rays, electrons, neutrons and ions.
Dr Karina Meredith was appointed Director of the new Research and Technology Group for Environment effective 15 January 2024.
The Accelerator Science group purse a broad research program with the aims of improving the performance and reliability of our accelerators, increasing their research capabilities and developing the next generation of accelerator technology.
Highlights on the Water Isotope Network project.
Australia launched a new international development project in partnership with the International Atomic Energy Agency (IAEA) to advance ‘Rays of Hope’ in the Asia and Pacific region.
The Think Science! event encourages students to engage with the Science Inquiry Skills process as outlined in the Australian National Curriculum.
The Macromolecular Crystallography beamlines at the Australian Synchrotron (MX1 and MX2) are general purpose crystallography instruments for determining chemical and biological structures.
Radiocarbon dating at ANSTO has supported research that vastly extends the known timeline of the Aboriginal occupation of South Australia’s Riverland region.
Research on the mechanism of cell death has insights to bring progress on neurodegenerative diseases and plant biosecurity.